Quarterly Result13 Nov 2025, 07:21 pm
Hamps Bio Ltd Reschedules Board Meeting to Approve Unaudited Financial Results for H1 2025
AI Summary
Hamps Bio Ltd, a company listed on the BSE, has announced the rescheduling of its Board Meeting. The meeting, initially scheduled for November 13, 2025, will now take place on November 14, 2025, at 4:00 PM at the corporate office. The purpose of the meeting is to consider, approve, and take on record the Unaudited Financial Results of the Company for the half-year ended September 30, 2025, in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has informed the BSE about this change in accordance with Regulation 29 of the same regulations.
Key Highlights
- Hamps Bio Ltd reschedules Board Meeting to November 14, 2025
- Meeting will consider and approve unaudited financial results for the half-year ended September 30, 2025
- Rescheduling is in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Meeting will be held at the corporate office of the Company
- Unaudited Financial Results will be taken on record as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Price Impact
More from HAMPS